%20(4).jpg)
Direct Answer
Untreated allergic rhinitis costs the average patient $2,000–$4,500 per year in direct expenses (OTC medications, urgent care visits, missed-work productivity loss) and gets more expensive over time as symptoms worsen, complications develop, and the condition progresses to asthma. Over a 10-year horizon, doing nothing costs $20,000–$50,000+, while treating the root cause with sublingual immunotherapy (SLIT) costs roughly $8,000–$12,000 total over 3–5 years—and then you are done, with lasting immune tolerance that reduces or eliminates future costs.
Year-by-Year Cost Model: Doing Nothing vs. Treating the Root Cause
This model compares two paths over 10 years for a typical moderate allergic rhinitis patient. All figures are based on published cost data from the AAAAI, CDC, and peer-reviewed health economics research. Your actual costs will vary based on severity, insurance coverage, and geographic location.
The gap between these two paths widens every year. Path A never stops costing money. Path B has a defined investment period followed by lasting returns.
Breaking Down the Hidden Costs of Untreated Allergies
Most people drastically underestimate what allergies cost them because the expenses are spread across dozens of small purchases and invisible productivity losses.
Direct Medication Costs
A typical moderate allergy sufferer’s monthly pharmacy bill includes a daily antihistamine ($15–$30/month for brand name, $8–$15 for generic), nasal corticosteroid spray ($15–$25/month OTC), eye drops ($10–$20/month), and decongestants or combination products during flares ($10–$20/month). That is $50–$95/month at minimum—$600–$1,140/year—just for over-the-counter products that treat symptoms without addressing the cause.
When OTC products are not enough, prescription medications add significantly: prescription nasal sprays like azelastine ($30–$80/month with insurance), leukotriene modifiers like montelukast ($15–$45/month), and combination inhalers if asthma develops ($100–$400/month with insurance).
Medical Visits
Untreated allergies lead to complications that generate medical visits. The CDC reports that allergic rhinitis results in approximately 12 million physician office visits annually in the United States. Common visit drivers include sinus infections (1–3 per year for chronic sufferers, $150–$400 per urgent care visit), ear infections (especially in children), asthma exacerbations requiring emergency care ($500–$3,000 per ER visit), and annual follow-ups with multiple specialists.
Lost Productivity: The Biggest Hidden Cost
Research published in the Journal of Allergy and Clinical Immunology estimates that allergic rhinitis causes an average of 3.5 missed workdays per year ("absenteeism") and the equivalent of an additional 11 reduced-productivity workdays per year ("presenteeism"—showing up but performing below capacity due to congestion, brain fog, fatigue, and medication side effects).
At the U.S. median hourly wage, those 14.5 lost-equivalent workdays represent approximately $1,700–$2,500 in annual productivity loss per employee. This is often the single largest cost of untreated allergies—and the one patients never calculate.
Sleep Quality and Downstream Health Costs
Nasal congestion disrupts sleep architecture. Chronic poor sleep from untreated allergic rhinitis contributes to increased accident risk, impaired cognitive function, worsened mental health (anxiety, depression), and cardiovascular strain. These downstream effects generate their own medical costs that are difficult to attribute directly to allergies but are very real.
Why Allergy Costs Escalate Over Time
Allergic rhinitis is not a static condition. Without treatment addressing the underlying immune dysfunction, it follows a predictable escalation pattern.
Sensitization Expands
Your immune system does not stop at the allergens you are currently reactive to. Each year of untreated allergic inflammation increases the probability of developing new sensitizations. A patient who starts with just spring tree pollen allergy may develop grass pollen sensitivity by year 2–3, ragweed sensitivity by year 4–5, and dust mite or mold sensitivity—making it a year-round problem—by year 6–10. More allergens means more months of symptoms, more medications, and higher costs.
The Allergic March
The “atopic march” describes the well-documented progression from allergic rhinitis to asthma. The AAAAI reports that 40% of allergic rhinitis patients eventually develop asthma if the rhinitis is left untreated. Asthma adds $3,000–$5,000 per year in treatment costs (inhalers, controller medications, pulmonologist visits, potential ER visits) and carries serious quality-of-life and safety implications.
Chronic Sinusitis
Persistent untreated nasal inflammation leads to chronic sinusitis in a significant percentage of patients. Chronic sinusitis treatment can include repeated courses of antibiotics ($30–$80 each), nasal endoscopy ($300–$1,000), CT imaging ($200–$800), and in severe cases, sinus surgery ($5,000–$20,000+). These are costs that could have been prevented by treating the underlying allergic inflammation early.
The SLIT Investment: What You Actually Pay
Here is the real cost breakdown for the HeyPak® sublingual immunotherapy path through HeyAllergy:
Total out-of-pocket for a 4-year SLIT course (without insurance): approximately $2,500–$3,500 for HeyPak® drops plus $500–$800 for consultations. With insurance covering visits and labs, the total drops further.
Compare that to $32,700–$54,700 over 10 years of doing nothing.
Treatment Comparison: All Options Side by Side
SLIT through HeyAllergy offers the lowest annual cost of any root-cause treatment, with the added convenience of at-home administration and telemedicine oversight—no weekly injections, no clinic commute, no time off work for appointments.
When to See an Allergist
Book a telemedicine allergy consultation if:
- You have been buying OTC allergy medications for more than 2 seasons and symptoms keep coming back—you are on the “do nothing” cost escalator
- You are spending more than $50/month on allergy-related products (antihistamines, nasal sprays, eye drops, tissues, air purifiers) and want to know if there is a more cost-effective path
- Your allergies are affecting your work performance, sleep quality, or ability to exercise outdoors—the productivity cost alone may exceed the cost of treatment
- You have developed sinus infections, ear infections, or breathing problems that were not present when your allergies first started—this suggests disease progression
- You want to understand your specific allergen profile through blood testing so you can make an informed cost-benefit decision about immunotherapy
- You have been told you need allergy shots but want a more convenient, needle-free, at-home alternative
Frequently Asked Questions
How much do allergies cost per year if left untreated?
The average moderate allergic rhinitis patient spends $2,000–$4,500 per year on direct costs (OTC medications, urgent care visits) and indirect costs (missed work, reduced productivity). The CDC reports allergic rhinitis accounts for approximately 12 million physician visits and $3.4 billion in direct healthcare costs annually in the United States. Individual costs vary by severity, but the critical point is that these costs recur every year with no endpoint—and tend to increase as the condition progresses and complications like sinusitis or asthma develop.
Is sublingual immunotherapy worth the cost?
Sublingual immunotherapy (SLIT) costs approximately $564–$800 per year for HeyPak® allergy drops, with additional costs for the initial consultation and blood testing (often covered by insurance). Over a 3–5 year treatment course, the total investment is roughly $2,700–$4,800. After completing treatment, most patients maintain lasting immune tolerance with minimal or no ongoing medication costs. Compared to $32,700–$54,700 over 10 years of untreated allergies, SLIT pays for itself within the first 2–3 years.
Does insurance cover allergy drops?
HeyAllergy accepts Medicare and most major PPO health plans, including United Healthcare, Anthem Blue Cross, Blue Shield, Cigna, Aetna, Humana, Oscar, and Tricare. The telemedicine consultation (CPT 99204 new patient, CPT 99214 follow-up) and allergy blood testing are typically covered, reducing your out-of-pocket costs. HeyPak® drops themselves may or may not be covered depending on your plan. Contact your insurance provider with Tax ID: 85-0834175 to confirm your specific coverage for both the consultation and treatment.
How long does it take for allergy drops to work?
Most patients begin noticing symptom improvement within 3–6 months of starting HeyPak® allergy drops. The recommended treatment duration is 3–5 years for lasting immune tolerance. During the treatment period, many patients are able to reduce or eliminate their OTC medication use—so you start saving on medication costs well before the treatment course is complete. After completing SLIT, the immune tolerance typically persists long-term.
Are allergy drops cheaper than allergy shots?
Yes, in most cases. Allergy shots (subcutaneous immunotherapy / SCIT) cost $2,000–$4,000 per year when you include the injections, office visit copays, and time off work for weekly-to-monthly clinic appointments. SLIT with HeyPak® costs $564–$800 per year for the drops alone, administered at home with no clinic visits beyond telemedicine follow-ups. Both treat the root cause and produce lasting tolerance, but SLIT eliminates the clinic commute, needles, and time-off-work costs that make shots more expensive in practice.
What happens if I stop treating my allergies?
If you stop OTC medications or prescription treatments, symptoms return immediately because these only suppress symptoms—they do not change your immune system. If you stop SLIT after completing a full 3–5 year course, the immune tolerance you built typically persists for years to decades. This is the fundamental difference: medications are an ongoing expense with no lasting benefit, while SLIT is a time-limited investment with lasting returns.
Author, Review and Disclaimer
Author: Krikor Manoukian, MD, FAAAAI, FACAAI — Board-Certified Allergist/Immunologist
Bio: Dr. Manoukian is a board-certified allergist/immunologist with over 20 years of experience. He leads HeyAllergy’s clinical team and specializes in telemedicine-enabled allergy care and personalized sublingual immunotherapy programs.
Medical Review: HeyAllergy Clinical Team (Board-Certified Allergists/Immunologists)
Disclaimer: Cost estimates in this article are based on published research and national averages. Your actual costs will vary based on insurance coverage, geographic location, allergy severity, and individual treatment needs. This article is educational and not a substitute for personalized financial or medical advice. Consult your insurance provider and a board-certified allergist for cost estimates specific to your situation.
References
- Meltzer EO, Bukstein DA. The economic impact of allergic rhinitis and current guidelines for treatment. Annals of Allergy, Asthma & Immunology. 2011;106(2 Suppl):S12-S16.
- Lamb CE, et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States. Current Medical Research and Opinion. 2006;22(6):1203-1210.
- AAAAI, Rhinitis (Hay Fever) Overview and Treatment Guidelines. AAAAI
- CDC, FastStats — Allergies and Hay Fever. CDC
